Вклад участника
- 18:59, 24 апреля 2024 (разн. | история) . . (+3657) . . Н Phase-The-second-Randomized-Review-involving-Spartalizumab-PDR001-a-good-AntiPD1-Antibody-Compared-to-Chemotherapy-throughout-Patients-With-RecurrentMetastatic-Nasopharyngeal-Cancer-malignancy-p (Phase-The-second-Randomized-Review-involving-Spartalizumab-PDR001-a-good-AntiPD1-Antibody-Compared-to-Chemotherapy-throughout-Patients-With-RecurrentMetastatic-Nasopharyngeal-Cancer-malignancy-p) (текущая)